Neurotech Leaders to Gather in SF Oct. 21-22. Brain Waves: The field of neurotechnology, the focus of this blog, encompasses advances in brain science (neurons), information technology (bits) and bioengineering (genes). Up for discussion and analysis: the political, economic, ethical, and social forces that will shape the future of what will be one of the most important and fascinating stories of the coming decades.

About this author

Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev

Receive by email

GUEST AUTHOR ARCHIVES

In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

« Brainy Scientists at UPenn | Main | Pills Alone Don't Solve Problems »

September 22, 2005

Neurotech Leaders to Gather in SF Oct. 21-22

Posted by Zack Lynch

Business leaders from across the neurotechnology industry will gather in San Francisco for a two-day investment and management conference for neurotech entrepreneurs, executives and investors.

Sessions at the Neurotech Leaders Forum to be held on October 20-21 at the Crowne Plaza Hotel will cover a range of technologies and market segments in the neurodevice sector, including neuromodulation, neural prostheses, neurodiagnostics, and neurostimulation. Attendees will hear from some of the leading researchers and entrepreneurs developing clinically and commercially promising products such as cochlear implants, stroke rehabilitation devices, implanted pain stimulators, neural-computer interfaces, and advanced brain sensing technologies.

The afternoon of the first day of the conference features two intensive courses for neurotechnology professionals, one devoted to funding opportunities and the other to fundamentals of the technology. The second day of the conference features a keynote address from Alan Levy, President and CEO of Northstar Neuroscience Inc. There will also be panel discussions on key issues affecting the industry, such as regulatory and reimbursement issues, licensing, and partnering.

Topics to be covered include: Basics of Neurotechnology with Warren Grill, Ph.D, Senior Technical Editor, Neurotech Reports; Neuropharmacology Industry Fundamentals with Zack Lynch, Managing Director, NeuroInsights; Launching a Neurotech Startup with Alan Levy, Ph.D., President and CEO, Northstar Neuroscience; Neurotechnology Industry Update with James Cavuoto, Editor and Publisher, Neurotech Reports; The Role of Government in Neurotechnology with Glenn Cornett, M.D., Ph.D., Senior Financial Editor, Neurotech Reports, Joe Pancrazio, Ph.D, National Institutes of Health, Jeff Newman, California Technology and Commerce Agency, Gail Schechter, BioIntelligence; Entrepreneur Panel with James Cavuoto, Mark Carney, CEO, Andara Life Science, Elisabeth Hager, CEO, GentCorp., and Andrew Barriskill, CEO, Restorative Therapies, Inc.; New Technologies Panel with Warren Grill and John McDonald, M.D., Ph.D., Director, International Center for Spinal Cord Injury; and Venture Capital Firms Perspective with Leslie Bottorff, Onset Ventures, Roger Quy, Technology Partners, Daniel O'Connell, NeuroVentures Capital, Alex Arrow, Lazard Capital Markets.

Comments (0) + TrackBacks (0) | Category: Neurodevices

POST A COMMENT

Thanks for signing in, . Now you can comment. (sign out)

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)